FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 101 through 150 of 320

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
CTOR Nasdaq Citius Oncology, Inc. 2836
CUE Nasdaq Cue Biopharma, Inc. 2836
CVAC Nasdaq CureVac N.V. 2836
CYTK Nasdaq Cytokinetics, Incorporated 2836
DAWN Nasdaq Day One Biopharmaceuticals, Inc. 2836
DBVT Nasdaq DBV Technologies S.A. 2836
DMAC Nasdaq DiaMedica Therapeutics Inc. 2836
DNA New York Ginkgo Bioworks Holdings, Inc. 2836
DNLI Nasdaq Denali Therapeutics Inc. 2836
DNTH Nasdaq Dianthus Therapeutics, Inc. 2836
DRMA Nasdaq Dermata Therapeutics, Inc. 2836
DRTS Nasdaq Alpha Tau Medical Ltd. 2836
DRUG Nasdaq Bright Minds Biosciences Inc. 2836
DSGN Nasdaq Design Therapeutics, Inc. 2836
DTIL Nasdaq Precision BioSciences, Inc. 2836
DWTX Nasdaq Dogwood Therapeutics, Inc. 2836
DYAI Nasdaq Dyadic International, Inc. 2836
DYN Nasdaq Dyne Therapeutics, Inc. 2836
EBS New York Emergent BioSolutions Inc. 2836
ELUT Nasdaq Elutia Inc. 2836
ENSC Nasdaq Ensysce Biosciences, Inc. 2836
ENTX Nasdaq Entera Bio Ltd. 2836
EQ Nasdaq Equillium, Inc. 2836
ERAS Nasdaq Erasca, Inc. 2836
ERNA Nasdaq Ernexa Therapeutics Inc. 2836
ESPR Nasdaq Esperion Therapeutics, Inc. 2836
ETHZ Nasdaq ETHZilla Corporation 2836
ETNB Nasdaq 89bio, Inc. 2836
EXAS Nasdaq Exact Sciences Corporation 2836
EXOZ Nasdaq eXoZymes, Inc. 2836
FATE Nasdaq Fate Therapeutics, Inc. 2836
FBIO Nasdaq Fortress Biotech, Inc. 2836
FENC Nasdaq Fennec Pharmaceuticals Inc. 2836
FGEN Nasdaq FibroGen, Inc. 2836
FHTX Nasdaq Foghorn Therapeutics Inc. 2836
FOLD Nasdaq Amicus Therapeutics, Inc. 2836
GANX Nasdaq Gain Therapeutics, Inc. 2836
GBIO Nasdaq Generation Bio Co. 2836
GDTC Nasdaq CytoMed Therapeutics Limited 2836
GELS Nasdaq Gelteq Limited 2836
GERN Nasdaq Geron Corporation 2836
GLSI Nasdaq Greenwich LifeSciences, Inc. 2836
GLUE Nasdaq Monte Rosa Therapeutics, Inc. 2836
GMED New York Globus Medical, Inc. 2836
GNLX Nasdaq Genelux Corporation 2836
GNPX Nasdaq Genprex, Inc. 2836
GNTA Nasdaq Genenta Science S.p.A. 2836
HALO Nasdaq Halozyme Therapeutics, Inc. 2836
HCWB Nasdaq HCW Biologics Inc. 2836
HOTH Nasdaq Hoth Therapeutics, Inc. 2836
Results 100 through 150 of 320